L R Salgado

739 total citations
22 papers, 546 citations indexed

About

L R Salgado is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Neurology. According to data from OpenAlex, L R Salgado has authored 22 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 4 papers in Neurology. Recurrent topics in L R Salgado's work include Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (12 papers) and Adrenal and Paraganglionic Tumors (10 papers). L R Salgado is often cited by papers focused on Pituitary Gland Disorders and Treatments (22 papers), Growth Hormone and Insulin-like Growth Factors (12 papers) and Adrenal and Paraganglionic Tumors (10 papers). L R Salgado collaborates with scholars based in Brazil, United States and Switzerland. L R Salgado's co-authors include Marcello D. Bronstein, Raquel S. Jallad, Nina Rosa de Castro Musolino, Stephan Petersenn, John Newell‐Price, James W. Findling, Mario Maldonado, Jochen Schopohl, Beverly M. K. Biller and Mirta Knoepfelmacher and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Heart Journal and Clinical Endocrinology.

In The Last Decade

L R Salgado

21 papers receiving 529 citations

Peers

L R Salgado
Ermelinda Guerra Italy
Katrin Ritzel Germany
Christina Berr Germany
Mirta Knoepfelmacher Brazil
Montserrat Gilabert Spain
Eigil Husted Nielsen Denmark
Monique Martinie France
Ana Laura Espinosa de los Monteros Mexico
Federico Vignati Italy
J. S. Bevan United Kingdom
Ermelinda Guerra Italy
L R Salgado
Citations per year, relative to L R Salgado L R Salgado (= 1×) peers Ermelinda Guerra

Countries citing papers authored by L R Salgado

Since Specialization
Citations

This map shows the geographic impact of L R Salgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L R Salgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L R Salgado more than expected).

Fields of papers citing papers by L R Salgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L R Salgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L R Salgado. The network helps show where L R Salgado may publish in the future.

Co-authorship network of co-authors of L R Salgado

This figure shows the co-authorship network connecting the top 25 collaborators of L R Salgado. A scholar is included among the top collaborators of L R Salgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L R Salgado. L R Salgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleseriu, Maria, L R Salgado, Tânia Longo Mazzuco, et al.. (2019). Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study. Frontiers in Endocrinology. 10. 436–436. 15 indexed citations
2.
Petersenn, Stephan, L R Salgado, Jochen Schopohl, et al.. (2017). Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial. Endocrine. 57(1). 156–165. 38 indexed citations
3.
Petersenn, Stephan, L R Salgado, Jochen Schopohl, et al.. (2015). Long-term (5 years) treatment of Cushing's disease with pasireotide. Endocrine Abstracts. 2 indexed citations
4.
5.
Pivonello, Rosario, Stephan Petersenn, John Newell‐Price, et al.. (2014). Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study. Clinical Endocrinology. 81(3). 408–417. 84 indexed citations
6.
Petersenn, Stephan, John Newell‐Price, James W. Findling, et al.. (2013). High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clinical Endocrinology. 80(2). 261–269. 95 indexed citations
7.
Schopohl, Jochen, Jérôme Bertherat, W.H. Ludlam, et al.. (2012). Long-term pasireotide use leads to improvements in the biochemical parameters of Cushing's disease: 24-month results from a randomized phase III study. 4 indexed citations
8.
Bertherat, Jérôme, W.H. Ludlam, Rosario Pivonello, et al.. (2012). Long-term use of pasireotide in Cushing's disease: 24-month safety results from a randomized phase III study. 7 indexed citations
9.
Pivonello, Rosario, John Newell‐Price, James W. Findling, et al.. (2011). Improvement in clinical signs and symptoms of Cushing's disease following 12 months' pasireotide therapy.
10.
Colao, Annamaria, Stephan Petersenn, John Newell‐Price, et al.. (2011). Pasireotide (SOM230) demonstrates efficacy in patients with Cushing's disease: results from a large, randomized-dose, double-blind, Phase III study. 2 indexed citations
11.
12.
Jallad, Raquel S., Nina Rosa de Castro Musolino, L R Salgado, & Marcello D. Bronstein. (2007). Treatment of acromegaly: is there still a place for radiotherapy?. Pituitary. 10(1). 53–59. 39 indexed citations
13.
Jallad, Raquel S., Nina Rosa de Castro Musolino, L R Salgado, & Marcello D. Bronstein. (2005). Treatment of acromegaly with octreotide‐LAR: extensive experience in a Brazilian institution. Clinical Endocrinology. 63(2). 168–175. 68 indexed citations
14.
Salgado, L R, et al.. (2005). Cushing Syndrome and Pregnancy. The Endocrinologist. 15(3). 135–138. 2 indexed citations
15.
Vieira, Marcelo, Charles Mady, Bernardo Liberman, et al.. (2002). Treatment of acromegaly improves myocardial abnormalities. American Heart Journal. 143(5). 873–876. 30 indexed citations
16.
Glezer, Andréa, Catarina Brasil d’Alva, L R Salgado, et al.. (2002). Pitfalls in pituitary diagnosis: peculiarities of three cases. Clinical Endocrinology. 57(1). 135–139. 14 indexed citations
17.
Cukiert, Arthur, et al.. (2001). Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors. Journal of Endocrinological Investigation. 24(2). 83–87. 12 indexed citations
18.
Wajchenberg, B L, et al.. (1996). Growth Hormone Axis in Cushing’s Syndrome. Hormone Research. 45(1-2). 99–107. 38 indexed citations
19.
FARIA, AMILTON C. S., Márcia Nery, L R Salgado, et al.. (1995). Growth hormone pulsatility in active and cured acromegalic subjects.. The Journal of Clinical Endocrinology & Metabolism. 80(12). 3767–3770. 28 indexed citations
20.
Salgado, L R, Berenice B. Mendonça, Jayme Goldman, et al.. (1995). Failure of partial hypophysectomy as definitive treatment in cushing’s disease owing to nodular corticotrope hyperpiasia; report of four cases. Endocrine Pathology. 6(1). 57–66. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ermelinda Guerra Breakdown of academic impact, for papers by Katrin Ritzel Breakdown of academic impact, for papers by Christina Berr Breakdown of academic impact, for papers by Mirta Knoepfelmacher Breakdown of academic impact, for papers by Montserrat Gilabert Breakdown of academic impact, for papers by Eigil Husted Nielsen Breakdown of academic impact, for papers by Monique Martinie Breakdown of academic impact, for papers by Ana Laura Espinosa de los Monteros Breakdown of academic impact, for papers by Federico Vignati Breakdown of academic impact, for papers by J. S. Bevan
Rankless by CCL
2026